Savings & Support

Start here for help with your BENLYSTA prescription.

Morgan (right), real BENLYSTA patient compensated by GSK

Beginning a new treatment can feel challenging, but you’re not alone.

Concerned about cost and support? We’re here to help.

BENLYSTA patient Racquel walking outside holding a yoga mat.

Racquel, real BENLYSTA patient compensated by GSK

Every month, eligible patients save on BENLYSTA with the BENLYSTA Copay Program.

The BENLYSTA Copay Program helps eligible commercially insured patients with their eligible out-of-pocket costs for BENLYSTA up to $9,450 annually, subject to program maximums. Visit GSKCopayPrograms.com for information about additional program limitations and complete Program Terms and Conditions.

Apply Now

BENLYSTA Copay Program FAQs

Expand AllCollapse All

  • What is the BENLYSTA Copay Program?

    The BENLYSTA Copay Program helps eligible commercially insured patients with their eligible out-of-pocket costs for BENLYSTA. Eligibility restrictions and program maximums apply. Visit GSKCopayPrograms.com for complete Program Terms and Conditions. Check your eligibility now.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.

  • Who is eligible for the BENLYSTA Copay Program?

    Patients may be eligible for the BENLYSTA Copay Program if they meet each of the general criteria below:

    1. Patient has a commercial medical or prescription insurance plan.
    2. Patient is a resident of the United States (including the District of Columbia, Puerto Rico, and the US Virgin Islands).
    3. Patient is not eligible for or enrolled in a government-funded program that provides prescription drug coverage.*

    *Patients are not eligible for this program if they are covered by any federal or state prescription insurance program. This includes patients enrolled in Medicare Part B, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DoD) programs or TRICARE. This may also include state pharmaceutical assistance programs and other federal or state plans not listed. Patients are also ineligible for this program if they are Medicare-eligible and enrolled in an employer-sponsored group waiver health plan or government-subsidized prescription drug benefit program for retirees. Patients enrolled in a state- or federally-funded prescription insurance program may not use this program even if they elect to be processed as an uninsured (cash paying) patient. Those on Medicare Part D, even if in the coverage gap, are not eligible. Patients enrolled in private indemnity or HMO insurance plans that reimburse them for the entire cost of their prescription drugs are also not eligible.

    Additional program rules apply. Visit GSKCopayPrograms.com for complete Terms and Conditions.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.

  • What are my potential savings with the BENLYSTA Copay Program?

    Eligible commercially insured patients may pay as little as $0 for BENLYSTA, subject to program maximums * 

    *The BENLYSTA Copay Program helps eligible commercially insured patients with their eligible out-of-pocket costs for BENLYSTA up to $9,450 annually.

    Visit GSKCopayPrograms.com  for information about additional program limitations and complete Program Terms and Conditions.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
BENLYSTA Cares Logo

No insurance? On Medicare or Medicaid?

GSK may provide you with BENLYSTA at no cost if you are eligible.

Did you know that GSK has a foundation to help patients who are not commercially insured cover the cost of medicine? It's called the GSK Patient Assistance Program (PAP).* To see if you're eligible, visit GSKForYou.com.

*The GSK Patient Assistance Program is offered by the GSK PAP Foundation.

BENLYSTA Savings & Support FAQs

Expand AllCollapse All

Hear the stories of other lupus warriors.

See how other people with lupus took the next step with BENLYSTA.

Meet BENLYSTA Patients

Make your next appointment more productive.

Be informed and prepared for your next doctor’s visit with a discussion guide.

Get Your Guide

What is BENLYSTA & Safety Info
What is BENLYSTA?

For people ≥5 years with active SLE (lupus) or active lupus nephritis on other lupus medicines. Not for people with severe active central nervous system lupus. Serious side effects may include death, life-threatening brain infection (PML), and certain cancers. Tell your doctor ... [Continue Reading]

BENLYSTA is a prescription medicine used to treat people 5 years of age and older with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis (LN) (lupus-related kidney inflammation) who are receiving other lupus medicines. It is not known if BENLYSTA is safe/effective in people with severe active central nervous system lupus.

It is not known if BENLYSTA, given under the skin, is safe/effective in:

  • children with SLE under 5 years of age or weighing less than 33 lbs
  • children with LN under 18 years of age

It is not known if BENLYSTA, given in a vein (intravenously), is safe and effective in children less than 5 years of age.

Important Safety Information

Do not use BENLYSTA if you are allergic to belimumab or any ingredients in BENLYSTA.

The most important information about BENLYSTA 
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these may cause death.

  • Infections: fever, chills, pain, or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.